Výsledky vyhledávání - "N. M. Chowhan"

Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT

Autor: Rafat Ansari, Barrett H. Childs, Howard S. Hochster, Ramesh K. Ramanathan, N. M. Chowhan, M. Keaton, John D. Hainsworth, Steven R. Alberts, Kendrith M. Rowland, Lowell L. Hart, Axel Grothey

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 25(6)

Background Oxaliplatin is an integral component of colorectal cancer treatment, but its use is limited by neurotoxicity. The Combined Oxaliplatin Neurotoxicity Prevention Trial (CONcePT) tested intermittent oxaliplatin (IO) administration and the use

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cee8ceb581e9a87ea5662561648348d
https://pubmed.ncbi.nlm.nih.gov/24608198

Zobrazit plný text záznamu

PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification

Autor: Steven J. Kussick, K. T. Doner, James A. Reeves, João Raposo, Hyeon-Seok Eom, G. Tumyan, Ian W. Flinn, Stephen J. Noga, N. M. Chowhan, Aleksandra Rizo, Cheolwon Suh, Fritz Offner, George Mulligan, Burhan Ferhanoglu, S. Aung, John P. Leonard, Julio Hajdenberg, Brian Ulrich, K. B. Pendergrass

Publikováno v: Journal of Clinical Oncology. 29:TPS226-TPS226

TPS226 Background: The recognition of prognostically distinct subtypes of DLBCL by gene expression profiling has, until now, not led to improved outcomes. Conducting targeted studies in prospective...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9d84d89213bd321edb54d9b43235cf11
https://doi.org/10.1200/jco.2011.29.15_suppl.tps226

Zobrazit plný text záznamu

Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01–24/USO-023—Updated results

Autor: L. A. Mina, M. A. Neubauer, R. H. Ansari, R. Govindan, L. H. Einhorn, W. Fisher, D. Bruetman, N. M. Chowhan, C. Johnson, N. H. Hanna

Publikováno v: Journal of Clinical Oncology. 26:7519-7519

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1a34073a4cf9a90f56a9c3cbde29c04
https://doi.org/10.1200/jco.2008.26.15_suppl.7519

Zobrazit plný text záznamu

Immune (idiopathic) thrombocytopenic purpura (ITP) treatment pattern and clinical efficacy

Autor: N. M. Chowhan, C. Ze, B. Deeter, John J. Isitt, B. Kamenova, Robert Robles

Publikováno v: Journal of Clinical Oncology. 26:17529-17529

17529 Background: Immune (Idiopathic) Thrombocytopenic Purpura (ITP) is an autoimmune disorder characterized by persistent thrombocytopenia (peripheral blood platelet count

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30e786dbb305cb48131a881853112d44
https://doi.org/10.1200/jco.2008.26.15_suppl.17529

Zobrazit plný text záznamu

International study of lenalidomide in relapsed/refractory aggressive non-Hodgkin’s lymphoma

Autor: N. M. Chowhan, Jerome B. Zeldis, Jonathan Polikoff, I. Esseessee, T. E. Witzig, R. Greenberg, Annette Ervin-Haynes, Craig B. Reeder, Myron S. Czuczman, Dennis Pietronigro

Publikováno v: Journal of Clinical Oncology. 26:8509-8509

8509 Background: Lenalidomide is active with manageable side effects in non-Hodgkin’s lymphoma (NHL). This study aims to confirm the activity, safety, and predictors of response previously reported for lenalidomide in patients with relapsed/refract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a958c700a9ef1caadc857f2cca6990cb
https://doi.org/10.1200/jco.2008.26.15_suppl.8509

Zobrazit plný text záznamu

Intermittent oxaliplatin (oxali) administration and time-to-treatment-failure (TTF) in metastatic colorectal cancer (mCRC): Final results of the phase III CONcePT trial

Autor: Lowell L. Hart, A. Grothey, N. M. Chowhan, Howard S. Hochster, Kendrith M. Rowland, Steven R. Alberts, Rafat Ansari, A. Shpilsky

Publikováno v: Journal of Clinical Oncology. 26:4010-4010

4010 Background: About 60% of mCRC patients (pts) discontinue oxali prior to disease progression (PD), largely driven by cumulative neurotoxicity (NT). CONcePT (Combined Oxaliplatin Neurotoxicity Prevention Trial) was initiated to test if an intermit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::689a1fe9749ac80a732e5bcdcecec35b
https://doi.org/10.1200/jco.2008.26.15_suppl.4010

Zobrazit plný text záznamu

Management of metastases-induced acute pancreatitis in small cell carcinoma of the lung

Autor: N M, Chowhan, S, Madajewicz

Publikováno v: Cancer. 65(6)

Metastases-induced acute pancreatitis is an uncommon condition that has a poor prognosis. Risk factors of acute pancreatitis in known cases have been studied and there is a low survival rate with more than three risk factors on presentation regardles

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a9c321429f839c13fc2e959df2c8b998
https://pubmed.ncbi.nlm.nih.gov/2155057

Zobrazit plný text záznamu

Injurious effects of radiation on the esophagus

Autor: N M, Chowhan

Publikováno v: The American journal of gastroenterology. 85(2)

Esophageal damage secondary to radiation therapy to thoracic tumors is a major dose limiting complication. Concomitant use of chemotherapeutic agents enhance this problem which can appear as esophagitis early in the course of treatment or as strictur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::edad3b7e9dd059dc8c14d831ad699aa7
https://pubmed.ncbi.nlm.nih.gov/2405641

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání